Table 2.
A meta‐analysis of 14 studies (3272 patients) A higher total dose of human menopausal gonadotrophin was necessary (mean difference, 235.46 IU [95% Cl 16.62–454.30; P = 0.03]; standardized mean difference, 0.33 [95% Cl 0.08–0.58; P = 0.01])
A meta‐analysis of 14 studies (3272 patients) A higher total dose of human menopausal gonadotrophin was necessary (mean difference, 235.46 IU [95% Cl 16.62–454.30; P = 0.03]; standardized mean difference, 0.33 [95% Cl 0.08–0.58; P = 0.01])